Cryosite Ltd (CTE) TRADING HALT SUSPENDED

20mins delayed

Movement

1 Year Return


Cryosite Ltd Chart

Share price
Last
Change
Volume
Turnover
Market Cap $10.54 million
Today's Movement
Prev. Close
Open
Day Range -
VWAP
Historical Stats
52w Range -
4w Avg Volume
4w Avg Turnover
(delayed)

CTE Statistics

01 October

1,841 / 2,232

ASX Size Rank

1yr Return

vs Sector (1yr)

+392.60%

vs ASX 200 (1yr)

+422.92%

$10.54 million

Market Cap

Share Issue

46.86 million

All Ords (%)

N/A

Short Sold

0%

Current Fundamentals

01 October

7.1

PE Ratio

EPS ($)

0.032

Earnings Yield

14.04%

NTA ($)

-0.01

N/A

Dividend Yield

DPS ($)

-

Gross Div. Yield

-

Gross DPS ($)

-

Company Overview

Cryosite Limited (CTE) is a unique Australian biotech and biologics logistics company. The company's specialized biologics based services are grouped into two business lines - Cord Blood and Tissues Storage and Clinical Trials Logistics & Biorepository. Cryosite also provides specialized Bio-repository, Clinical Trials Logistics, Commercial Drug Distribution, contract Cellular Therapies manufacturing and associated consultancy services to commercial clients both within Australia and Internationally.

Former Names
--

Cryosite Ltd Logo

Corporate Details

Head Office: South Granville
Managing Director: Mark Byrne
GICS Sub-Industry: Life Sciences Tools & Services
Date Listed: 9 May 2002
Registry: Link Market Services
Similar Companies: GSS / ADO / OSL / PAL / MEM

Upcoming Calendar

25 Feb 2021 Report (Interim)
27 Aug 2021 Report (Prelim)
27 Aug 2021 Report (Annual)

Dividend History

Ex-Date Amount Franking Type Payable
14/03/2017 $0.005 0% Interim 31/03/2017
07/09/2016 $0.005 0% Final 04/10/2016
11/03/2016 $0.005 0% Interim 31/03/2016
08/09/2015 $0.005 0% Final 01/10/2015
13/03/2015 $0.005 0% Interim 31/03/2015
08/09/2014 $0.010 0% Final 24/09/2014
17/03/2014 $0.005 0% Interim 04/04/2014
23/09/2013 $0.010 0% Final 23/10/2013
18/03/2013 $0.005 0% Interim 05/04/2013

See Upcoming Dividends for all ASX companies.

Announcements

Date Heading Pages File Size Time

Announcements provided by

Broker Consensus

The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.

CTE is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.

Directors & Management

About the Data


Name Title Since Bio
Mr Andrew John Kroger Non-Executive Director Nov 2011
Mr Bryan Dulhunty Company Secretary, Executive Chairman, Executive Director Mar 2018
Mrs Nicola Swift Non-Executive Director Nov 2016

Director Transactions

About the Data

CTE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
17/04/20 Andrew Kroger Buy +49,422 $0.080 $3,953 On-market trade.
06/04/20 Andrew Kroger Buy +75,024 $0.074 $5,551 On-market trade.
13/03/20 Andrew Kroger Buy +571,716 $0.070 $40,015 On-market trade.
09/03/20 Andrew Kroger Buy +7,000 $0.070 $490 On-market trade.
04/03/20 Andrew Kroger Transfer 713,590 $0.070 $49,951 Off-market transfer.
04/03/20 Andrew Kroger Buy +371,159 $0.067 $24,872 On-market trade.
30/08/19 Andrew Kroger Buy +500,000 $0.057 $28,500 Off-market trade.
04/07/19 Bryan Dulhunty Issued 1,300,000 $0.050 $65,000 Issue of options.
22/03/18 Andrew Kroger Buy +672,500 $0.110 $73,975 Off-market trade.
14/03/18 Andrew Kroger Buy +625,885 $0.110 $68,547 On-market trade.
14/03/18 Andrew Kroger Transfer 41,090 $0.110 $4,519 Off-market transfer.
09/10/17 Stephen Roberts Buy +298,500 $0.150 $44,721 On-market trade.
30/06/17 Andrew Kroger Transfer 41,090 $0.160 $6,574 Off-market transfer.
30/06/17 Andrew Kroger Buy +1,327,500 $0.190 $252,225 Off-market trade.
30/06/17 Andrew Kroger Buy +72,500 $0.160 $11,600 On-market trade.
03/01/17 Stephen Roberts Buy +12,500 $0.175 $2,188 On-market trade.
14/12/16 Stephen Roberts Buy +7,700 $0.118 $905
14/12/16 Stephen Roberts Buy +7,700 $0.118 $905 On-market trade.
07/12/16 Stephen Roberts Buy +4,446 $0.204 $905
31/08/16 Andrew Kroger Buy +1,300,000 $0.220 $286,000
30/06/16 Andrew Kroger Buy +41,090 $0.207 $8,517
30/11/15 Graeme Moore Expiry 300,000 $0.275 $82,500
24/11/15 Andrew Kroger Buy +1,300,000 $0.275 $357,500
08/09/15 Christina (Christy) Boyce Buy +39,193 $0.251 $9,828
02/03/15 Christina (Christy) Boyce Buy +40,000 $0.392 $15,660
02/03/15 Andrew Kroger Buy +268,873 $0.406 $109,187
09/09/13 Andrew Kroger Buy +1,000,000 $0.530 $530,000
25/06/13 Christina Boyce Buy +38,941 $0.430 $16,763
18/06/13 Christina Boyce Buy +1,059 $0.467 $495

Shareholder Distribution

About the Data

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over Total Shareholders
No. of Shareholders 38 217 61 100 41 457

Top 20 Shareholders

About the Data

Name Shares Capital
Andrew Kroger and related entities 18,889,612 40.31%
Cell care Australia Pty Ltd 9,129,995 19.48%
Bnp Paribas Nominees Pty Ltd 2,087,384 4.45%
Mr. Alistair David Strong 2,000,000 4.27%
Bell Potter Nominees Ltd 1,758,236 3.75%
Mrs. Jane Susan Milliken 1,302,917 2.78%
Mr. Stephen Roberts 967,662 2.07%
Sunnyit Pty Ltd 851,000 1.82%
H F A Administration Pty Limited 480,000 1.02%
CVF Australia Pty Ltd 459,085 0.98%
Paradyce Pty Ltd 379,000 0.81%
Mr. Gary Griffith Robins 325,000 0.69%
Castlereagh Equity Pty Ltd 300,000 0.64%
Wifam Investments Pty Ltd 300,000 0.64%
Integument Pty Ltd 262,013 0.56%
Wheen Finance Pty Limited 228,454 0.49%
Mr. Peter Howells 215,730 0.46%
MNJ Holdings 214,931 0.46%
Naron Nominees Pty Ltd 213,007 0.45%
Mantou Republic Pty Ltd 200,000 0.43%
All other shareholders 13.44 %


The Top 20 Shareholders of CTE hold 86.56% of shares on issue.

CTE Share Price History

Date Close Change % Change Open High Low Volume Turnover

CTE Historical Data

Download up to 20 years of share price history.


Year Closing Price (30 June) Last Trade
2020 $0.13 30 June
2019 $0.05 28 June
2018 $0.09 29 June
2017 $0.16 28 June
2016 $0.21 28 June
2015 $0.35 30 June
2014 $0.36 30 June

Offical data as published by ASX. See more Data Downloads.

Company Details

Principal Activity: Provision of supply chain logistics, management of pharmaceutical products used in clinical trials, management of biological materials and long-term storage of cord blood and tissue samples.

Incorporated: in NSW in December 1999.

13a Ferndell St
South Granville NSW 2142


All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.